search
Back to results

Audiovisual Aid Pilot Study

Primary Purpose

Stress, Psychological

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Zeiss, Cinema ProMED (audiovisual equipment)
Midazolam
Skin Conductance Monitor
Sponsored by
Hospital for Special Surgery, New York
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stress, Psychological focused on measuring Audiovisual Aids, Perioperative Period, Anxiety

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients scheduled for primary, ambulatory, arthroscopic meniscectomy under spinal anesthesia

Exclusion Criteria:

  • Patients with psychiatric disease and those on antidepressants
  • Contraindications to spinal anesthesia or allergy to study medication
  • Age < 18 years
  • Patients with audiovisual impairments
  • Patients with inability to communicate in English or understand the study requirements
  • Chronic pain patients +/- opioid use
  • Patients with (neuro)dermatoses encompassing the hand
  • Patients with pacemakers
  • Patients with diabetes or known neuropathic disease
  • Patients with a history of epilepsy or seizure disorder
  • Patients with a history of claustrophobia
  • Patients with a history of epilepsy
  • Patients with prior history of epilepsy or seizure disorder
  • Patients undergoing a revision or open procedure

Sites / Locations

  • Hospital for Special Surgery (HSS)

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Sedation only with skin conductance monitor

Sedation & audiovisual aids with skin conductance monitor

Arm Description

Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.

Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.

Outcomes

Primary Outcome Measures

Skin Conductance Response
Primary outcome will be number of skin conductance responses per second (SCR/sec) and amplitude of skin conductance responses averaged over time in 5 minute intervals and at key time points such before, during and after insertion of an IV, discussion with surgeon, anesthesiologist, immediately before leaving the holding area, immediately after entering the OR, during application of monitors, before and after administration of sedatives, before, during and after spinal insertion, incision, immediately prior to leaving the OR, after arrival at PACU and monitors are placed, before discharge from the PACU.

Secondary Outcome Measures

Beats Per Minute (BPM)
The change in heart rate from holding area until PACU discharge.
Systolic and Diastolic Blood Pressure
The maximum change in postoperative systolic and diastolic blood pressure from holding area until PACU discharge.
Respiratory Rate
The maxmimum change in postoperative respiratory rate from holding area until PACU discharge.
Number of Patients Who Requested Additional Sedation
Number of patients who requested additional sedative medication in the operating room.
Pain Numerical Rating Scale (NRS) Levels
Pain scores at rest will be collected from patients using the numerical rating scale (NRS), which asks patients to report their level of pain on a scale from 0 to 10, where 0 represents no pain and 10 represents the worst possible pain. NRS levels in holding area, PACU until discharge from the PACU and one day after surgery, postop day 1.
Narcotic Consumption
Narcotic consumption "intraop", "postop" and "POD1"
State-Trait Anxiety Inventory Questionnaire (STAI)
Questionnaire to measure state anixety levels based on a 4-point likert scale and consists of 40 questions. The questionnaire measures two types of anxiety: state anxiety and trait anxiety. State anxiety relates to anxiety about an event, while trait anxiety in anxiety level as a personal characteristic. Scores can range from 20 to 80 and higher scores correlate with more anxiety.
Heidelberg Peri-anaesthetic Questionnaire
The questionnaire consists of 38 questions assessing perioperative satisfaction about five identified themes: trust and atmosphere; fear; discomfort; treatment by personnel; and information and waiting. The questions are rated on a 4-point Likert scale ranging from 0 (unimportant to me) to 3 (very important to me). Higher scores indicate higher levels of satisfaction. Patient satisfaction (Heidelberg Peri-Anaesthetic Questionnaire) in PACU upon spinal resolution.
Client Satisfaction Questionnaire (CSQ-8)
The client satisfaction questionnaire (CSQ-8) is a standardized satisfaction measure and was used to collect patient feedback on the audio visual devices. Response options differ, but all are on a 4-point scale. Scores range from 8 to 32, with higher values indicating higher satisfaction. Patient feedback (CSQ8) in PACU upon spinal resolution provider feedback (form sent to providers at end of surgery day)
Number of Providers That Were Satisfied With Their Experience With the Audio-visual Aids
Anesthesia providers were asked to provide feedback on their experience with the audio-visual aids when the randomization was for the use of the device. This was collected upon surgery end.
Request of Sedation/Termination of AVA
Request of Sedation/Termination of AVA (After consent has been obtained until spinal resolution in the recovery room, average of 6 hours)
Number of Participants With Complications
The percentage of patients who experienced complications (headache, transient neurologic symptoms, nausea and vomiting, ...)

Full Information

First Posted
July 2, 2015
Last Updated
February 3, 2020
Sponsor
Hospital for Special Surgery, New York
search

1. Study Identification

Unique Protocol Identification Number
NCT02506673
Brief Title
Audiovisual Aid Pilot Study
Official Title
The Effect of Audiovisual Aids on Perioperative Stress Response, Pain and Overall Experience - a Randomized Controlled Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
February 2020
Overall Recruitment Status
Completed
Study Start Date
January 14, 2016 (Actual)
Primary Completion Date
May 2017 (Actual)
Study Completion Date
July 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospital for Special Surgery, New York

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Little is known about perioperative stress responses and possible anxiety mitigating factors like audiovisual aids or IV sedation. Most studies use surrogate markers and retrospective questionnaires, and are not based on real-time gathered data. Skin conductance measurements allow the sympathetic discharge to be evaluated down to fractions of a second and enable us to continuously monitor stress responses as skin conductance responses/per second during the perioperative management. In our study, the investigators propose to examine the effect of personal audiovisual equipment (audio/video goggles) on perioperative stress, pain, and overall experience in patients undergoing ambulatory meniscectomy under spinal anesthesia. Patients will be randomly assigned to either receive traditional sedation or light sedation in addition to audiovisual equipment. The investigators hope to determine outcome estimates of the use of this equipment on stress levels using skin conductance measurements, request for further sedation, postoperative pain levels and analgesic consumption, time to discharge readiness, and overall patient satisfaction, and collect thus far unavailable data on the stress response to perioperative stresses (such as IV insertion and spinal placement) in order to allow for power analyses for future studies.
Detailed Description
PLEASE NOTE: After conducting the interim analysis and plotting the skin conductance data, we have determined that the graphs are not consistent enough to draw any conclusions. Given the technical difficulties we have encountered with the Med-Storm Stress Detector, as well as the labor intensity associated with it, we have decided that we will no longer use it from patient 14 on. We will not mark the time points and hand movements described in the protocol, as this data was used to understand the skin conductance data. We will continue to enroll patients to complete this pilot/exploratory study, as the other secondary outcomes--in particular, the surveys--could provide valuable information.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stress, Psychological
Keywords
Audiovisual Aids, Perioperative Period, Anxiety

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
26 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Sedation only with skin conductance monitor
Arm Type
Active Comparator
Arm Description
Patients will receive traditional sedation with 2 mg of midazolam on arrival in the OR. Patients in this group will wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Arm Title
Sedation & audiovisual aids with skin conductance monitor
Arm Type
Experimental
Arm Description
Prior to surgery, patients will be asked to wear audiovisual equipment (Zeiss, Cinema ProMED) in the holding area. Patients in this group will also receive 2 mg of midazolam on arrival in OR. Patients in this group will also wear the skin conductance monitor to measure changes in levels of sympathetic discharge.
Intervention Type
Device
Intervention Name(s)
Zeiss, Cinema ProMED (audiovisual equipment)
Intervention Type
Drug
Intervention Name(s)
Midazolam
Intervention Type
Device
Intervention Name(s)
Skin Conductance Monitor
Primary Outcome Measure Information:
Title
Skin Conductance Response
Description
Primary outcome will be number of skin conductance responses per second (SCR/sec) and amplitude of skin conductance responses averaged over time in 5 minute intervals and at key time points such before, during and after insertion of an IV, discussion with surgeon, anesthesiologist, immediately before leaving the holding area, immediately after entering the OR, during application of monitors, before and after administration of sedatives, before, during and after spinal insertion, incision, immediately prior to leaving the OR, after arrival at PACU and monitors are placed, before discharge from the PACU.
Time Frame
Measured in 5 minute intervals, from holding area until PACU discharge.
Secondary Outcome Measure Information:
Title
Beats Per Minute (BPM)
Description
The change in heart rate from holding area until PACU discharge.
Time Frame
Measured from preop to postop
Title
Systolic and Diastolic Blood Pressure
Description
The maximum change in postoperative systolic and diastolic blood pressure from holding area until PACU discharge.
Time Frame
Measured from preop to postop
Title
Respiratory Rate
Description
The maxmimum change in postoperative respiratory rate from holding area until PACU discharge.
Time Frame
Measured from preop to postop
Title
Number of Patients Who Requested Additional Sedation
Description
Number of patients who requested additional sedative medication in the operating room.
Time Frame
In the operating room
Title
Pain Numerical Rating Scale (NRS) Levels
Description
Pain scores at rest will be collected from patients using the numerical rating scale (NRS), which asks patients to report their level of pain on a scale from 0 to 10, where 0 represents no pain and 10 represents the worst possible pain. NRS levels in holding area, PACU until discharge from the PACU and one day after surgery, postop day 1.
Time Frame
Holding area, Postop (PACU, 30 minutes after arrival to PACU and POD1)
Title
Narcotic Consumption
Description
Narcotic consumption "intraop", "postop" and "POD1"
Time Frame
Preop until 24 hours after surgery (holding area until POD 1)
Title
State-Trait Anxiety Inventory Questionnaire (STAI)
Description
Questionnaire to measure state anixety levels based on a 4-point likert scale and consists of 40 questions. The questionnaire measures two types of anxiety: state anxiety and trait anxiety. State anxiety relates to anxiety about an event, while trait anxiety in anxiety level as a personal characteristic. Scores can range from 20 to 80 and higher scores correlate with more anxiety.
Time Frame
holding area and PACU
Title
Heidelberg Peri-anaesthetic Questionnaire
Description
The questionnaire consists of 38 questions assessing perioperative satisfaction about five identified themes: trust and atmosphere; fear; discomfort; treatment by personnel; and information and waiting. The questions are rated on a 4-point Likert scale ranging from 0 (unimportant to me) to 3 (very important to me). Higher scores indicate higher levels of satisfaction. Patient satisfaction (Heidelberg Peri-Anaesthetic Questionnaire) in PACU upon spinal resolution.
Time Frame
At PACU upon spinal resolution.
Title
Client Satisfaction Questionnaire (CSQ-8)
Description
The client satisfaction questionnaire (CSQ-8) is a standardized satisfaction measure and was used to collect patient feedback on the audio visual devices. Response options differ, but all are on a 4-point scale. Scores range from 8 to 32, with higher values indicating higher satisfaction. Patient feedback (CSQ8) in PACU upon spinal resolution provider feedback (form sent to providers at end of surgery day)
Time Frame
PACU upon spinal resolution
Title
Number of Providers That Were Satisfied With Their Experience With the Audio-visual Aids
Description
Anesthesia providers were asked to provide feedback on their experience with the audio-visual aids when the randomization was for the use of the device. This was collected upon surgery end.
Time Frame
Sent to providers at end of surgery.
Title
Request of Sedation/Termination of AVA
Description
Request of Sedation/Termination of AVA (After consent has been obtained until spinal resolution in the recovery room, average of 6 hours)
Time Frame
From consent until spinal resolution (avg 6 hs)
Title
Number of Participants With Complications
Description
The percentage of patients who experienced complications (headache, transient neurologic symptoms, nausea and vomiting, ...)
Time Frame
Intraoperatively and in the recovery room, average of 3 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients scheduled for primary, ambulatory, arthroscopic meniscectomy under spinal anesthesia Exclusion Criteria: Patients with psychiatric disease and those on antidepressants Contraindications to spinal anesthesia or allergy to study medication Age < 18 years Patients with audiovisual impairments Patients with inability to communicate in English or understand the study requirements Chronic pain patients +/- opioid use Patients with (neuro)dermatoses encompassing the hand Patients with pacemakers Patients with diabetes or known neuropathic disease Patients with a history of epilepsy or seizure disorder Patients with a history of claustrophobia Patients with a history of epilepsy Patients with prior history of epilepsy or seizure disorder Patients undergoing a revision or open procedure
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Stavros G. Memtsoudis, MD, PhD
Organizational Affiliation
Hospital for Special Surgery, New York
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital for Special Surgery (HSS)
City
New York
State/Province
New York
ZIP/Postal Code
10021
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Audiovisual Aid Pilot Study

We'll reach out to this number within 24 hrs